Palantir Technologies Inc., a leading provider of AI systems, and Option Care Health Inc., the nation’s largest independent national provider of home and alternate...
insitro, a machine learning-powered drug discovery and development company, announced the appointment of S. Michael Rothenberg, M.D., Ph.D., as chief medical officer. In this...
Swoop, a leader in developing precise direct to consumer (DTC) and healthcare provider (HCP) audiences for pharmaceutical and life sciences brands, announced the launch...
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, announced a research collaboration with NVIDIA to accelerate the...
Nabla, the leading ambient AI assistant for practitioners, announced the initial close of a $24M Series B funding round led by Cathay Innovation, with participation from ZEBOX...
Deep 6 AI, a leading AI-powered precision research platform for healthcare organizations and life sciences companies, announced its partnership with Graticule, an on-demand, advanced real-world...
Isomorphic Labs, a digital biology company with a mission to redefine drug discovery using the power of artificial intelligence, announced that it has entered...
Quris-AI, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, announced the addition of Michel Vounatsos, former CEO of Biogen, to its Board of Directors,...
Chicago-based Evozyne announced Marc Yoskowitz as CEO of the generative AI-driven biotech.
Yoskowitz, most recently chief strategy officer and executive vice president, life sciences, at...
Nanotronics, the Industrial AI company, announced a new strategic partnership with OrbiMed, a leading global life sciences investment firm. As part of the transaction,...